Brandes Investment Partners LP Has $97.55 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Brandes Investment Partners LP increased its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 8.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,653,045 shares of the pharmacy operator’s stock after buying an additional 126,930 shares during the quarter. [...]

featured-image

Brandes Investment Partners LP increased its position in shares of CVS Health Co. ( NYSE:CVS – Free Report ) by 8.3% during the second quarter, according to the company in its most recent 13F filing with the SEC.

The firm owned 1,653,045 shares of the pharmacy operator’s stock after buying an additional 126,930 shares during the quarter. Brandes Investment Partners LP owned about 0.13% of CVS Health worth $97,553,000 at the end of the most recent quarter.



A number of other hedge funds have also recently added to or reduced their stakes in the company. Regal Investment Advisors LLC grew its position in CVS Health by 16.4% in the 2nd quarter.

Regal Investment Advisors LLC now owns 82,350 shares of the pharmacy operator’s stock valued at $4,864,000 after purchasing an additional 11,617 shares during the period. Wallace Advisory Group LLC acquired a new position in shares of CVS Health during the second quarter valued at about $457,000. William B.

Walkup & Associates Inc. bought a new position in CVS Health in the 2nd quarter valued at about $1,269,000. Magnolia Capital Advisors LLC acquired a new position in CVS Health during the 2nd quarter valued at about $795,000.

Finally, Ascent Group LLC raised its stake in shares of CVS Health by 14.6% in the second quarter. Ascent Group LLC now owns 20,188 shares of the pharmacy operator’s stock worth $1,192,000 after purchasing an additional 2,578 shares during the last quarter.

Institutional investors and hedge funds own 80.66% of the company’s stock. Analyst Ratings Changes Several equities research analysts recently issued reports on the company.

Evercore ISI decreased their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a report on Thursday, August 8th.

Deutsche Bank Aktiengesellschaft reduced their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th.

Barclays dropped their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th.

Wells Fargo & Company upped their target price on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th.

Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research report on Monday, September 16th. Eleven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock.

Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $72.10. CVS Health Trading Up 4.

0 % NYSE:CVS opened at $61.38 on Monday. The company has a debt-to-equity ratio of 0.

83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.

25. The company has a market cap of $77.05 billion, a P/E ratio of 10.

79, a P/E/G ratio of 0.81 and a beta of 0.53.

The stock’s fifty day moving average price is $58.20 and its two-hundred day moving average price is $61.87.

CVS Health ( NYSE:CVS – Get Free Report ) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.

73 by $0.10. CVS Health had a return on equity of 12.

72% and a net margin of 1.98%. The firm had revenue of $91.

23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same period in the prior year, the business posted $2.

21 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis.

As a group, analysts expect that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be issued a $0.665 dividend.

The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.

33%. CVS Health’s payout ratio is currently 46.75%.

About CVS Health ( Free Report ) CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also Five stocks we like better than CVS Health How to Evaluate a Stock Before Buying 3 Bargain Stocks Under $20 With Major Growth Potential Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness Top 5 ETFs to Own Now and Into 2025 What are earnings reports? Watch These 3 Former Short-Squeeze Stocks for a Big Rally Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter ..